Bcr-Abl variants:: biological and clinical aspects

被引:86
作者
Advani, AS
Pendergast, AM
机构
[1] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, LSRC, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Hematol & Oncol, Durham, NC 27710 USA
关键词
Philadelphia chromosome; Bcr-Abl; acute lymphocytic leukemia; chronic myelogenous leukemia; chronic neutrophilic leukemia;
D O I
10.1016/S0145-2126(01)00197-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bcr-Abl is an oncogene that arises from fusion of the Bcr gene with the c-Abl proto-oncogene. Three different Bcr-Abl variants can be formed, depending on the amount of Bcr gene included: p185, p210, and p230. The three variants are associated with distinct types of human leukemias. Examination of the signaling pathways differentially regulated by the Bcr-Abl proteins will help us gain better insight into Bcr-Abl mediated leukemogenesis. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:713 / 720
页数:8
相关论文
共 148 条
[111]   Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases [J].
Quackenbush, RC ;
Reuther, GW ;
Miller, JP ;
Courtney, KD ;
Pear, WS ;
Pendergast, AM .
BLOOD, 2000, 95 (09) :2913-2921
[112]   POLYMERASE CHAIN-REACTION DETECTION OF THE BCR-ABL FUSION TRANSCRIPT AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - RESULTS AND IMPLICATIONS IN 346 PATIENTS [J].
RADICH, JP ;
GEHLY, G ;
GOOLEY, T ;
BRYANT, E ;
CLIFT, RA ;
COLLINS, S ;
EDMANDS, S ;
KIRK, J ;
LEE, A ;
KESSLER, P ;
SCHOCH, G ;
BUCKNER, CD ;
SULLIVAN, KM ;
APPELBAUM, FR ;
THOMAS, ED .
BLOOD, 1995, 85 (09) :2632-2638
[113]  
Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI DOI 10.1016/S0304-419X(97)00023-1
[114]   THE BCR-ABL LEUKEMIA ONCOGENE ACTIVATES JUN KINASE AND REQUIRES JUN FOR TRANSFORMATION [J].
RAITANO, AB ;
HALPERN, JR ;
HAMBUCH, TM ;
SAWYERS, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11746-11750
[115]  
REARDON DA, 1994, CANCER, V73, P1526, DOI 10.1002/1097-0142(19940301)73:5<1526::AID-CNCR2820730534>3.0.CO
[116]  
2-E
[117]   A requirement for NF-κB activation in Bcr-Abl-mediated transformation [J].
Reuther, JY ;
Reuther, GW ;
Cortez, D ;
Pendergast, AM ;
Baldwin, AS .
GENES & DEVELOPMENT, 1998, 12 (07) :968-981
[118]   THE SMALL GTP-BINDING PROTEIN RHO REGULATES THE ASSEMBLY OF FOCAL ADHESIONS AND ACTIN STRESS FIBERS IN RESPONSE TO GROWTH-FACTORS [J].
RIDLEY, AJ ;
HALL, A .
CELL, 1992, 70 (03) :389-399
[119]   The Src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase [J].
Roumiantsev, S ;
de Aos, IE ;
Varticovski, L ;
Ilaria, RL ;
Van Etten, RA .
BLOOD, 2001, 97 (01) :4-13
[120]   NEW CONSISTENT CHROMOSOMAL ABNORMALITY IN CHRONIC MYELOGENOUS LEUKEMIA IDENTIFIED BY QUINACRINE FLUORESCENCE AND GIEMSA STAINING [J].
ROWLEY, JD .
NATURE, 1973, 243 (5405) :290-293